Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identifying a polymorphic 'switch' that influences miRNAs' regulation of a myasthenia gravis risk pathway.

PloS one - 1 Jan 2014

Yang Lili, Wang Jianjian, Sun Xuesong, Cao Yuze, Ning Shangwei, Zhang Huixue, Chen Lixia, Li Ronghong, Tian Qinghua, Wang Lihua, Wang Weizhi, Li Xia

Abstract excerpt

The significant roles of genetic variants in myasthenia gravis (MG) pathogenesis have been demonstrated in many studies, and recently it has been revealed that aberrant level/regulation of microRNAs (miRNAs) might contribute to the initiation and progression of MG. However, the dysfunction of miRNA associated with single nucleotide polymorphisms (miRSNPs) has not been well investigated in MG. In this study, we...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Case-Control Studies
Share to Data Mining

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Databases, Nucleic Acid

Share to Genes, Switch

Share to MicroRNAs

Share to Models, Genetic

Share to Myasthenia Gravis

Share to Signal Transduction

Source

Open in PubMed Open full text

Identifiers

PMID: 25118158
DOI: 10.1371/journal.pone.0104827
PMCID: PMC4130595

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identifying a polymorphic 'switch' that influences miRNAs' regulation of a myasthenia gravis risk pathway.PMID 25118158Read ↗

Competitive endogenous RNA network and pathway-based analysis of LncRNA single-nucleotide polymorphism in myasthenia gravis.Semantic proximity Read ↗

Construction of an miRNA-regulated drug-pathway network reveals drug repurposing candidates for myasthenia gravisSemantic proximity Read ↗

Whole-genome analysis in Korean patients with autoimmune myasthenia gravis.Semantic proximity Read ↗

Non-coding RNA and its network in the pathogenesis of Myasthenia GravisSemantic proximity Read ↗

Genetic basis of myasthenia gravis - a comprehensive review.Semantic proximity Read ↗

A Review on the Role of Non-Coding RNAs in the Pathogenesis of Myasthenia Gravis.Semantic proximity Read ↗

Identification of the regulatory role of lncRNA HCG18 in myasthenia gravis by integrated bioinformatics and experimental analysesSemantic proximity Read ↗

CFD+CD14+ monocytes: potential pathogenic subset in myasthenia gravis uncovered by multi-omics integration and machine learning analysis.Semantic proximity Read ↗

Identification of key regulatory factors for m6A in myasthenia gravis and characteristics of the immune characteristicsSemantic proximity Read ↗

Construction of a TF–miRNA–gene feed-forward loop network predicts biomarkers and potential drugs for myasthenia gravisSemantic proximity Read ↗

Identification of the Regulatory Role of lncRNA SNHG16 in Myasthenia Gravis by Constructing a Competing Endogenous RNA NetworkSemantic proximity Read ↗

Plasma exosomal miR‐106a‐5p expression in myasthenia gravisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.